Arezzo Pathways showcased at Long-Term Conditions Conference

On Tuesday 21st January 2014 InferMed demonstrated how the Arezzo Pathways clinical decision support tool is making a significant difference to the care of patients with long-term conditions at the Long-Term Conditions Conference that took place at the QEII Conference Centre in the heart of Westminster.

 

On Tuesday 21st January 2014 the Long-Term Conditions Conference (http://long-term-conditions-conference.co.uk) took place at the QEII Conference Centre in the heart of Westminster, attracting an audience focussed on the improved delivery of care in this area. InferMed was at the adjoining exhibition demonstrating the Arezzo Pathways clinical decision support tool that is making a significant difference to the care of patients with long-term conditions.

The one-day event was designed to facilitate understanding and allow access to knowledge, information, and networking around the most important issues surrounding the current long-term condition management agenda.

The opening keynote speech was given by Bob Ricketts, Director of Commissioning Support Strategy and Market Development, NHS England, on service transformation through commissioning and establishing effective processes to achieve quality outcomes. Other speakers included Professor Gillian Leng CBE, Deputy Chief Executive and Director of Health and Social Care at NICE and Simon Gillespie, Chief Executive of the British Heart Foundation.

InferMed joined this key conference to underline the important contribution its Arezzo Pathways tool can make in the transformation of patient care, supporting clinicians in using evidence-based care to drive improved outcomes. This support provides assured compliance with care pathways, decision recommendations based on best available evidence and predictive risk factors and tailored prescribing.

The challenge of proactively managing patients with long-term conditions and identifying ‘at risk’ patients in order to target interventions is growing. With Arezzo Pathways a patient’s care is managed in the optimal way for their condition at any point in time and in accordance with best practice protocols and local resource provision. As a result, outcomes are improved, the cost of care is optimised, the number of hospital admissions falls and clinical variance can be minimised.

Duane Lawrence, InferMed CEO, commented, “The Long-Term Conditions Conference website acknowledged that a key area in the successful transformation of the care of patients with long-term conditions is the effective use of technology. We are proud to have exhibited Arezzo Pathways at this conference, as we see the enormous potential this has to transform care in this area, and enjoyed demonstrating its benefits to the conference delegates.”

If you were not able to attend the conference, but you would like a demonstration of Arezzo Pathways, please send us a request via our Contact form.